Weizmann Team Identifies DARE Cells That Survive Caspase Activation to Drive Fly Tissue Repair

The study recreated classic 1970s radiation experiments on fly larvae using modern genetic sensors to track cells that initiate but escape apoptosis. DARE cells showed transient caspase activity followed by proliferation and tissue replacement, while NARE cells resisted death without caspase engagement. Both populations contributed to compensatory proliferation, a process observed across species since the 1970s but previously unexplained at the molecular level.

Published in Nature Communications, the work builds on prior findings from the Arama lab and others demonstrating non-lethal caspase roles in differentiation and immunity. It suggests cancer cells may hijack this survival switch, contributing to post-treatment recurrence, a link not fully tested here but consistent with clinical patterns of therapy-resistant tumors.

Human translation remains unproven; analogous cells have not been confirmed in mammalian skin or epithelia. Strengthening evidence would require targeted caspase sensors in human organoids or patient-derived xenografts to measure survival and regenerative capacity under controlled damage.

The discovery reframes caspases as tunable regulators rather than binary death switches, opening routes to enhance repair while blocking tumor escape.